For Healthcare Professionals

Pediatric Patients With Metabolic or Other Genetic Disorders

clipboard-pencil

About the study

Background: Some patients with unusual genetic conditions are referred to the National Institutes of Health (NIH). They may not be eligible to join current research studies. Testing such patients is a good way to improve the skills of research staff. The findings could lead to new processes and research. Objectives: To recruit a diverse group of pediatric subjects with genetic disorders. To give clinic staff hands-on experience working with these patients. Eligibility: Children any age with a known or suspected genetic disorder. Design: Participants will be screened with medical history and physical exam. They may have lab and other tests. Family members may give DNA samples. Participants will have: Medical history Physical exam Height, weight, and other measurements taken. A clinical evaluation of their disorder. They may have: Blood, urine, and saliva samples taken Imaging tests. These may include x-rays, scans, ultrasound, or skeletal survey. A sleep study A visit with other specialists at NIH A genetic test from a commercial lab Medical photographs taken Other tests Participants may have follow-up visits. They may get medical or surgical treatment.
user-3

Who can take part

You may be eligible to participate in the study if you meet the following criteria:

INCLUSION CRITERIA

INCLUSION CRITERIA:

  • Subjects of any age with known or suspected genetic disorder
  • Subjects determined by a study investigator to be appropriate for clinical training
  • Subject engaged in care with a community-based healthcare provider
  • For relatives of subjects with a genetic disorder:

    Subject is a family member of the proband

    EXCLUSION CRITERIA

    EXCLUSION CRITERIA:

    -Presence of a medical, psychiatric, or social condition which, in the opinion of the investigator, would place undue burden on the subject, NIH resources, or increase risk of participation

    pin location

    Study Locations

    Enter your ZIP code/Postal code/PIN code to locate study sites near you:

    How to Apply


    Contact the study center to learn if this study is a good match for you.

    Study’s details


    Contition

    Genetic Disorder,Asperger Disorder,Autism Spectrum Disorder,Fragile X Syndrome,Developmental Delay

    Participants needed

    5000

    Est. Completion Date

    Jan 1, 2029

    Treatment type

    Observational


    Sponsor

    National Institutes of Health Clinical Center (CC)

    ClinicalTrials.gov identifier

    NCT02769949

    Study number

    160-103

    Understanding Clinical Trials


    Get answers to your questions about clinical trials.What is a clinical research?What does taking part in clinical trials involve?What should I ask the trial doctor?
    Vector

    Interested?

    Sign up to save your favorites, 
    receive newsletters, resources, and alerts 
    about clinical trials related to your conditions of interest.